Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
Status:
Not yet recruiting
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
ERASE PH-COPD is a randomized double-blind study, with 2 parallel groups. Patients with
severe pulmonary hypertension due to chronic obstructive pulmonary disease, will be randomly
assigned to receive Tadalafil orally or placebo.